Maximize merger arbitrage growth returns

Out maneuver the market and identify potential regulatory hurdles for mergers and acquisitions with MLex. Our exclusive market insight, analysis and commentary covers deals from pre-notification through notification, review and approval.

The world's leading hedge funds use the MLex DealRisk service to analyze deals through notification, review, approval and compliance with daily case updates on M&A clearance.

As reported first by MLex

Like to read the full text of these, or any other MLex insights? Request a trial subscription via the form at the bottom of the page.

Bayer, Mon­santo deal faces in-depth scrutiny in China as Phase 2 review begins

4 May 2017

DOJ to an­nounce approval of $12.5 billion Danone­-WhiteWave merger

3 April 2017

Wal­greens con­siders offering key Rite Aid assets to trans­form Fred's, get FTC ap­proval

8 March 2017

Key Deals

Our coverage includes exclusive insight and analysis on the following key deals around the globe.

USA

United States of America

Walgreens/Rite Aid
Sherwin Williams/Valspar
AT&T/Time Warner
Dow/DuPont
Bayer/Monsanto
GE/Baker Hughes
Abbott/Alere
Aetna/Humana
Anthem/Cigna
Virtu Financial/KCG Holdings

EU

European Union

Dow / DuPont
Bayer / Monsanto
Qualcomm / NXP
Twenty-First Century Fox / Sky
Knorr-Bremse / Haldex
Praxair / Linde
J&J / Actelion
GE / Baker Hughes
Broadcom / Brocade
PPG / AkzoNobel
Essilor / Luxottica
Intel / Mobileye

Asia

Asia

Qualcomm/NXP
Broadcom/Brocade
ASE/Siliconware
Bayer/Monsanto
GE/Baker Hughes
Maersk Line/Hamburg Sud

Latin America

Latin America

Dow / DuPont
Bayer / Monsanto
Kroton/Anhanguera
Praxair / Linde
Essilor / Luxottica

Request a free MLex trial

Looking for breaking news and to review regulatory implications for specific deals? Complete the form to request a free, limited trial to MLex.